a development stage company, which focuses on treatment of diabetes
Industry Biotechnology
A.I.dvisor tells us that ORGS and LOGC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORGS and LOGC's prices will move in lockstep.
Ticker / NAME | Correlation To ORGS | 1D Price Change % | ||
---|---|---|---|---|
ORGS | 100% | -5.74% | ||
LOGC - ORGS | 29% Poorly correlated | N/A | ||
FATE - ORGS | 27% Poorly correlated | -5.02% | ||
KMSTF - ORGS | 25% Poorly correlated | N/A | ||
CRBU - ORGS | 24% Poorly correlated | -3.03% | ||
AXON - ORGS | 24% Poorly correlated | -1.54% | ||
More |